Leblanc, Andréa C
$925,650.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2017-2018
Canada
Validation of the Nlrp1-Casp1-Casp6 pathway as an early therapeutic target of age-dependent cognitive impairment and Alzheimer Disease.